Mylan Inc. to Build New Corporate Headquarters

PITTSBURGH, March 9, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it plans to build a new corporate headquarters near its current location in the Southpointe Office Park located in Cecil Township, Washington County, Pa., just south of Pittsburgh.

Mylan Executive Chairman Robert J. Coury said: "Mylan's global operations have experienced transformational and phenomenal growth over the last five years, and we expect this growth will only continue in the years to come. In order to support our expanding business, we have more than doubled the number of employees located at our corporate headquarters in this same time frame, and we would expect hiring in the area to continue."

Coury continued: "I am very pleased to announce that we are committed to remain in the Pittsburgh area, and in the Southpointe Office Park, in particular. Construction and design of the new facility will focus on the growing needs of our global business, our dedicated employees as well as current and future environmental impact. This facility, in combination with all of our extraordinary assets, will continue to build upon our one-of-a-kind global operating platform and support Mylan's commitment to setting new standards in health care and providing the world's seven billion people with access to high quality medicine."

Mylan is planning to develop its corporate headquarters building within Southpointe II. The site is located within the Town Center Overlay District located along Town Center Boulevard. The overall development is planned to include an approximate 280,000 square foot, five-story, LEED-certified, Class-A office building with associated infrastructure and parking. The building is expected to be completed in 2013.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in approximately 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.

SOURCE Mylan Inc.